Bryan Bergman
Concepts (433)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin Resistance | 51 | 2024 | 1164 | 8.860 |
Why?
| Muscle, Skeletal | 39 | 2024 | 1628 | 5.370 |
Why?
| Triglycerides | 17 | 2024 | 523 | 3.190 |
Why?
| Diabetes Mellitus, Type 2 | 23 | 2024 | 2429 | 2.920 |
Why?
| Sphingolipids | 8 | 2024 | 69 | 2.910 |
Why?
| Diglycerides | 8 | 2024 | 61 | 2.390 |
Why?
| Adipose Tissue | 16 | 2023 | 589 | 2.310 |
Why?
| Obesity | 34 | 2025 | 2858 | 2.280 |
Why?
| Exercise | 14 | 2024 | 1929 | 2.180 |
Why?
| Insulin | 26 | 2024 | 2315 | 1.860 |
Why?
| Blood Glucose | 29 | 2025 | 2093 | 1.750 |
Why?
| Fasting | 7 | 2025 | 264 | 1.710 |
Why?
| Lipids | 5 | 2024 | 620 | 1.630 |
Why?
| Physical Endurance | 12 | 2020 | 264 | 1.510 |
Why?
| Glucose Clamp Technique | 22 | 2025 | 194 | 1.500 |
Why?
| Ceramides | 7 | 2024 | 104 | 1.460 |
Why?
| Phosphatidylcholines | 2 | 2024 | 146 | 1.340 |
Why?
| Sarcolemma | 3 | 2024 | 40 | 1.240 |
Why?
| Rest | 6 | 2017 | 122 | 1.200 |
Why?
| Liver | 12 | 2019 | 1826 | 1.130 |
Why?
| Muscle Fibers, Skeletal | 5 | 2024 | 189 | 1.120 |
Why?
| Lipogenesis | 4 | 2017 | 59 | 1.110 |
Why?
| Fatty Acids, Nonesterified | 10 | 2022 | 159 | 1.040 |
Why?
| Intra-Abdominal Fat | 4 | 2022 | 88 | 0.970 |
Why?
| Prediabetic State | 5 | 2016 | 245 | 0.960 |
Why?
| Weight Loss | 4 | 2025 | 725 | 0.930 |
Why?
| Glucose | 9 | 2023 | 982 | 0.910 |
Why?
| Glucagon-Like Peptide 1 | 2 | 2023 | 112 | 0.880 |
Why?
| Receptors, Gastrointestinal Hormone | 1 | 2023 | 6 | 0.880 |
Why?
| Lipid Metabolism | 12 | 2024 | 491 | 0.870 |
Why?
| Glucose Tolerance Test | 11 | 2021 | 356 | 0.860 |
Why?
| Tandem Mass Spectrometry | 4 | 2024 | 449 | 0.830 |
Why?
| Dietary Fats | 6 | 2020 | 301 | 0.810 |
Why?
| Carnitine | 3 | 2024 | 76 | 0.790 |
Why?
| Diabetes Mellitus, Type 1 | 18 | 2019 | 3624 | 0.740 |
Why?
| Athletes | 7 | 2024 | 409 | 0.690 |
Why?
| Adult | 44 | 2025 | 35299 | 0.680 |
Why?
| Humans | 85 | 2025 | 128417 | 0.680 |
Why?
| Male | 64 | 2025 | 62857 | 0.650 |
Why?
| Energy Metabolism | 5 | 2025 | 831 | 0.640 |
Why?
| Female | 62 | 2025 | 68153 | 0.610 |
Why?
| Glucose Intolerance | 4 | 2014 | 142 | 0.560 |
Why?
| Subcutaneous Fat | 3 | 2024 | 74 | 0.560 |
Why?
| Hypoglycemic Agents | 2 | 2023 | 1212 | 0.560 |
Why?
| Oxidation-Reduction | 8 | 2024 | 1001 | 0.550 |
Why?
| Adipocytes | 2 | 2023 | 204 | 0.550 |
Why?
| Lactic Acid | 7 | 2009 | 293 | 0.550 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2019 | 475 | 0.550 |
Why?
| Phosphatidylethanolamines | 2 | 2017 | 74 | 0.540 |
Why?
| Choristoma | 1 | 2015 | 21 | 0.500 |
Why?
| Body Composition | 10 | 2025 | 644 | 0.490 |
Why?
| Mitochondria, Muscle | 5 | 2021 | 110 | 0.470 |
Why?
| Middle Aged | 28 | 2025 | 30889 | 0.470 |
Why?
| Smoking | 2 | 2012 | 1460 | 0.430 |
Why?
| Hyperglycemia | 3 | 2014 | 326 | 0.430 |
Why?
| Myocardium | 2 | 2009 | 965 | 0.430 |
Why?
| Benzhydryl Compounds | 1 | 2013 | 66 | 0.410 |
Why?
| Cross-Sectional Studies | 8 | 2024 | 5039 | 0.410 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2012 | 51 | 0.400 |
Why?
| Phenols | 1 | 2013 | 96 | 0.400 |
Why?
| Atrial Function | 2 | 2009 | 10 | 0.400 |
Why?
| Body Mass Index | 7 | 2025 | 2261 | 0.400 |
Why?
| Culture Media, Conditioned | 2 | 2022 | 108 | 0.390 |
Why?
| Fatty Acids | 5 | 2024 | 415 | 0.390 |
Why?
| Homeostasis | 1 | 2016 | 603 | 0.390 |
Why?
| Adiposity | 5 | 2024 | 504 | 0.390 |
Why?
| Lipoprotein Lipase | 2 | 2015 | 58 | 0.380 |
Why?
| Hyperinsulinism | 3 | 2024 | 119 | 0.370 |
Why?
| Physical Fitness | 4 | 2004 | 203 | 0.370 |
Why?
| Glycerol | 5 | 2015 | 87 | 0.360 |
Why?
| Animals | 28 | 2024 | 34479 | 0.350 |
Why?
| Sex Characteristics | 5 | 2024 | 721 | 0.350 |
Why?
| Sleep | 3 | 2021 | 676 | 0.350 |
Why?
| Incretins | 1 | 2010 | 18 | 0.350 |
Why?
| Sleep Deprivation | 3 | 2021 | 171 | 0.340 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 45 | 0.340 |
Why?
| Pyrazines | 1 | 2010 | 86 | 0.330 |
Why?
| Triazoles | 1 | 2010 | 147 | 0.310 |
Why?
| Physical Education and Training | 2 | 1999 | 75 | 0.310 |
Why?
| Cytosol | 2 | 2020 | 214 | 0.310 |
Why?
| Rats | 5 | 2024 | 5165 | 0.310 |
Why?
| Insulin-Secreting Cells | 2 | 2010 | 366 | 0.300 |
Why?
| Cardiac Pacing, Artificial | 1 | 2009 | 84 | 0.300 |
Why?
| Thinness | 2 | 2007 | 90 | 0.290 |
Why?
| Energy Intake | 4 | 2025 | 454 | 0.280 |
Why?
| Endoplasmic Reticulum | 2 | 2020 | 260 | 0.270 |
Why?
| Pulmonary Gas Exchange | 3 | 2007 | 117 | 0.260 |
Why?
| T-Lymphocytes | 5 | 2000 | 1923 | 0.260 |
Why?
| Young Adult | 13 | 2024 | 12312 | 0.260 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2018 | 169 | 0.250 |
Why?
| Palmitates | 2 | 2018 | 18 | 0.240 |
Why?
| Polycystic Ovary Syndrome | 2 | 2019 | 163 | 0.240 |
Why?
| Islets of Langerhans | 5 | 2000 | 790 | 0.230 |
Why?
| Heart Rate | 1 | 2008 | 800 | 0.230 |
Why?
| Adipose Tissue, White | 1 | 2024 | 37 | 0.220 |
Why?
| Body Weight | 2 | 2025 | 928 | 0.220 |
Why?
| Citric Acid Cycle | 2 | 2021 | 50 | 0.220 |
Why?
| Prostatic Neoplasms | 3 | 2020 | 1011 | 0.220 |
Why?
| Caloric Restriction | 1 | 2025 | 108 | 0.220 |
Why?
| Circadian Clocks | 1 | 2023 | 42 | 0.210 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 586 | 0.210 |
Why?
| Catecholamines | 1 | 2023 | 97 | 0.210 |
Why?
| Mitochondrial Diseases | 1 | 2023 | 88 | 0.210 |
Why?
| Adiponectin | 3 | 2015 | 234 | 0.210 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 431 | 0.210 |
Why?
| Isophane Insulin, Human | 1 | 2022 | 5 | 0.210 |
Why?
| Fatty Liver | 2 | 2016 | 231 | 0.210 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2022 | 18 | 0.200 |
Why?
| Gluconeogenesis | 2 | 2018 | 73 | 0.200 |
Why?
| Oxygen Consumption | 4 | 2016 | 669 | 0.200 |
Why?
| Adipokines | 1 | 2022 | 46 | 0.200 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.200 |
Why?
| Blotting, Western | 3 | 2016 | 1164 | 0.200 |
Why?
| Biopsy | 3 | 2018 | 1081 | 0.190 |
Why?
| Case-Control Studies | 5 | 2019 | 3328 | 0.190 |
Why?
| Dinoprostone | 1 | 2022 | 187 | 0.190 |
Why?
| Subcellular Fractions | 2 | 2021 | 80 | 0.190 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2023 | 207 | 0.190 |
Why?
| Histone Deacetylases | 1 | 2023 | 210 | 0.190 |
Why?
| Paracrine Communication | 1 | 2022 | 60 | 0.190 |
Why?
| Physical Conditioning, Animal | 1 | 2024 | 230 | 0.190 |
Why?
| Interleukin-13 | 1 | 2022 | 144 | 0.190 |
Why?
| Bone Marrow | 1 | 2023 | 267 | 0.190 |
Why?
| Stearoyl-CoA Desaturase | 3 | 2012 | 62 | 0.190 |
Why?
| Interleukin-8 | 1 | 2022 | 258 | 0.190 |
Why?
| Resistance Training | 1 | 2024 | 151 | 0.180 |
Why?
| Exercise Test | 5 | 2015 | 613 | 0.180 |
Why?
| Lipolysis | 2 | 2018 | 40 | 0.180 |
Why?
| Bone Remodeling | 1 | 2021 | 71 | 0.180 |
Why?
| Knee | 1 | 2001 | 61 | 0.170 |
Why?
| Diabetic Angiopathies | 3 | 2011 | 262 | 0.170 |
Why?
| Electric Stimulation | 1 | 2001 | 267 | 0.170 |
Why?
| Immunity | 1 | 2020 | 131 | 0.170 |
Why?
| Antigens, Surface | 1 | 2000 | 150 | 0.170 |
Why?
| Diabetic Neuropathies | 1 | 2021 | 90 | 0.170 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 378 | 0.170 |
Why?
| Autophagy-Related Proteins | 2 | 2017 | 41 | 0.160 |
Why?
| Palmitic Acid | 2 | 2010 | 40 | 0.160 |
Why?
| Autoantigens | 2 | 2000 | 416 | 0.160 |
Why?
| Calorimetry, Indirect | 3 | 2019 | 80 | 0.150 |
Why?
| Guanosine Triphosphate | 1 | 2018 | 92 | 0.150 |
Why?
| rac1 GTP-Binding Protein | 1 | 2018 | 52 | 0.150 |
Why?
| Interleukin-6 | 1 | 2022 | 716 | 0.150 |
Why?
| Obesity, Abdominal | 1 | 2018 | 47 | 0.150 |
Why?
| Kinetics | 6 | 2006 | 1615 | 0.150 |
Why?
| Primary Cell Culture | 1 | 2019 | 158 | 0.150 |
Why?
| Absorptiometry, Photon | 4 | 2025 | 248 | 0.150 |
Why?
| Basal Metabolism | 2 | 2008 | 57 | 0.140 |
Why?
| Metabolic Syndrome | 2 | 2013 | 338 | 0.140 |
Why?
| Muscle Contraction | 1 | 2001 | 420 | 0.140 |
Why?
| Cohort Studies | 5 | 2021 | 5388 | 0.140 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 258 | 0.140 |
Why?
| Mice | 13 | 2024 | 16602 | 0.140 |
Why?
| Cell Nucleus | 1 | 2020 | 578 | 0.140 |
Why?
| Diet | 4 | 2013 | 1199 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1185 | 0.140 |
Why?
| Diet, Western | 3 | 2023 | 79 | 0.140 |
Why?
| Pediatric Obesity | 1 | 2024 | 570 | 0.140 |
Why?
| Autophagy-Related Protein-1 Homolog | 1 | 2017 | 7 | 0.140 |
Why?
| Metabolomics | 3 | 2019 | 599 | 0.140 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2017 | 43 | 0.130 |
Why?
| Pregnancy | 7 | 2024 | 6357 | 0.130 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 429 | 0.130 |
Why?
| Biological Transport | 1 | 2017 | 394 | 0.130 |
Why?
| Phosphorylation | 4 | 2015 | 1681 | 0.130 |
Why?
| Gene Expression Profiling | 2 | 2023 | 1688 | 0.130 |
Why?
| Phenotype | 1 | 2024 | 3044 | 0.120 |
Why?
| Metformin | 1 | 2019 | 312 | 0.120 |
Why?
| Fatty Acids, Unsaturated | 1 | 2016 | 95 | 0.120 |
Why?
| Microtubule-Associated Proteins | 1 | 2017 | 190 | 0.120 |
Why?
| Circadian Rhythm | 1 | 2019 | 409 | 0.120 |
Why?
| Insulin Receptor Substrate Proteins | 2 | 2012 | 59 | 0.120 |
Why?
| Insulinoma | 2 | 1999 | 30 | 0.120 |
Why?
| Amino Acids | 1 | 2019 | 474 | 0.120 |
Why?
| Adolescent | 12 | 2024 | 20179 | 0.120 |
Why?
| Weight Gain | 1 | 2019 | 503 | 0.120 |
Why?
| Biomarkers | 4 | 2023 | 3880 | 0.120 |
Why?
| Pain | 1 | 2001 | 757 | 0.120 |
Why?
| Mitochondria | 2 | 2018 | 848 | 0.120 |
Why?
| Algorithms | 3 | 2015 | 1618 | 0.120 |
Why?
| Oxygen | 2 | 2015 | 899 | 0.120 |
Why?
| Cell Hypoxia | 1 | 2015 | 229 | 0.110 |
Why?
| RNA, Messenger | 3 | 2014 | 2675 | 0.110 |
Why?
| Coronary Artery Disease | 2 | 2011 | 678 | 0.110 |
Why?
| Receptors, AMPA | 1 | 2015 | 133 | 0.110 |
Why?
| Somatostatin | 1 | 2014 | 54 | 0.110 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 577 | 0.110 |
Why?
| Cytoplasmic Granules | 1 | 1994 | 78 | 0.110 |
Why?
| Neurodegenerative Diseases | 1 | 2015 | 110 | 0.110 |
Why?
| Fructose | 1 | 2014 | 106 | 0.110 |
Why?
| Fetal Development | 1 | 2016 | 283 | 0.110 |
Why?
| Regression Analysis | 1 | 2016 | 978 | 0.110 |
Why?
| Extracellular Vesicles | 1 | 2015 | 129 | 0.110 |
Why?
| Clone Cells | 4 | 2000 | 255 | 0.110 |
Why?
| Leg | 3 | 1999 | 240 | 0.100 |
Why?
| Medroxyprogesterone Acetate | 1 | 2012 | 35 | 0.100 |
Why?
| Macaca | 3 | 2018 | 50 | 0.100 |
Why?
| Taxoids | 1 | 2012 | 95 | 0.100 |
Why?
| Phospholipids | 2 | 2012 | 207 | 0.100 |
Why?
| Coronary Vessels | 2 | 2010 | 236 | 0.100 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 309 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 563 | 0.100 |
Why?
| Myocardial Reperfusion Injury | 1 | 2013 | 121 | 0.100 |
Why?
| Progestins | 1 | 2012 | 78 | 0.100 |
Why?
| Cholesterol | 2 | 2013 | 406 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2019 | 2505 | 0.090 |
Why?
| Hypoxia | 1 | 2018 | 1036 | 0.090 |
Why?
| Hemodynamics | 3 | 2008 | 1081 | 0.090 |
Why?
| Myocardial Contraction | 1 | 2013 | 330 | 0.090 |
Why?
| Recovery of Function | 1 | 2015 | 641 | 0.090 |
Why?
| Reference Values | 2 | 2010 | 776 | 0.090 |
Why?
| Child | 9 | 2024 | 20655 | 0.090 |
Why?
| Fenofibrate | 1 | 2011 | 31 | 0.090 |
Why?
| Estradiol | 2 | 2019 | 486 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1935 | 0.090 |
Why?
| Sitagliptin Phosphate | 1 | 2010 | 31 | 0.090 |
Why?
| Hypolipidemic Agents | 1 | 2011 | 93 | 0.090 |
Why?
| Nicotine | 1 | 2012 | 303 | 0.080 |
Why?
| Retinoid X Receptor gamma | 1 | 2009 | 4 | 0.080 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2012 | 380 | 0.080 |
Why?
| C-Peptide | 1 | 2010 | 163 | 0.080 |
Why?
| Metabolic Clearance Rate | 2 | 2006 | 103 | 0.080 |
Why?
| PPAR alpha | 1 | 2009 | 59 | 0.080 |
Why?
| Expiratory Reserve Volume | 1 | 2008 | 1 | 0.080 |
Why?
| Lipoproteins | 1 | 2010 | 171 | 0.080 |
Why?
| Mice, Inbred C57BL | 2 | 2023 | 5272 | 0.080 |
Why?
| Bicycling | 1 | 2010 | 118 | 0.080 |
Why?
| Calcinosis | 1 | 2011 | 230 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 940 | 0.080 |
Why?
| Gene Expression | 3 | 2023 | 1456 | 0.080 |
Why?
| Coronary Circulation | 1 | 2008 | 137 | 0.070 |
Why?
| Ethinyl Estradiol | 1 | 1988 | 17 | 0.070 |
Why?
| Signal Transduction | 4 | 2018 | 4826 | 0.070 |
Why?
| Calcium | 2 | 2010 | 1178 | 0.070 |
Why?
| Arteries | 2 | 2000 | 262 | 0.070 |
Why?
| Drug Resistance, Neoplasm | 1 | 2012 | 749 | 0.070 |
Why?
| Pancreatic Neoplasms | 2 | 1999 | 875 | 0.070 |
Why?
| Receptor, Insulin | 1 | 2007 | 99 | 0.070 |
Why?
| Regional Blood Flow | 2 | 1999 | 459 | 0.070 |
Why?
| Cardiovascular Diseases | 3 | 2018 | 1999 | 0.070 |
Why?
| Hyperphagia | 1 | 2006 | 33 | 0.070 |
Why?
| Overweight | 1 | 2011 | 524 | 0.060 |
Why?
| Adaptation, Physiological | 1 | 2010 | 514 | 0.060 |
Why?
| Heart | 1 | 2009 | 635 | 0.060 |
Why?
| Infant | 3 | 2024 | 8914 | 0.060 |
Why?
| Substance Withdrawal Syndrome | 1 | 1988 | 169 | 0.060 |
Why?
| Sex Factors | 4 | 2018 | 1945 | 0.060 |
Why?
| Sex Hormone-Binding Globulin | 2 | 2019 | 53 | 0.060 |
Why?
| Metabolome | 2 | 2019 | 319 | 0.060 |
Why?
| ARNTL Transcription Factors | 1 | 2023 | 16 | 0.060 |
Why?
| Ubiquinone | 1 | 2023 | 27 | 0.060 |
Why?
| Adipogenesis | 1 | 2024 | 49 | 0.050 |
Why?
| Uncoupling Protein 1 | 1 | 2023 | 15 | 0.050 |
Why?
| Pyruvic Acid | 1 | 2004 | 52 | 0.050 |
Why?
| Cardiorespiratory Fitness | 1 | 2024 | 49 | 0.050 |
Why?
| Electron Transport | 1 | 2023 | 112 | 0.050 |
Why?
| Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| Adipose Tissue, Brown | 1 | 2023 | 51 | 0.050 |
Why?
| Carbohydrate Metabolism | 2 | 2004 | 60 | 0.050 |
Why?
| Cell Line | 4 | 2018 | 2731 | 0.050 |
Why?
| AMP-Activated Protein Kinases | 1 | 2024 | 190 | 0.050 |
Why?
| Physical Exertion | 1 | 2004 | 208 | 0.050 |
Why?
| Insulin, Regular, Human | 1 | 2022 | 42 | 0.050 |
Why?
| Prognosis | 2 | 2023 | 3772 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2010 | 2721 | 0.050 |
Why?
| Diet, High-Fat | 1 | 2023 | 238 | 0.050 |
Why?
| Primates | 1 | 2023 | 118 | 0.050 |
Why?
| Time Factors | 2 | 2010 | 6482 | 0.050 |
Why?
| Neoplasms | 1 | 2017 | 2464 | 0.050 |
Why?
| Protein Binding | 2 | 2018 | 2103 | 0.050 |
Why?
| Osteocalcin | 1 | 2021 | 36 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 2071 | 0.050 |
Why?
| Acute Disease | 1 | 2024 | 964 | 0.050 |
Why?
| Proteins | 2 | 2015 | 932 | 0.050 |
Why?
| Swine, Miniature | 2 | 2013 | 79 | 0.050 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2015 | 173 | 0.050 |
Why?
| Oxidative Stress | 2 | 2018 | 1176 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 2012 | 2051 | 0.050 |
Why?
| Muscle Strength | 1 | 2024 | 305 | 0.040 |
Why?
| Ranolazine | 1 | 2020 | 25 | 0.040 |
Why?
| Adenocarcinoma | 1 | 1988 | 888 | 0.040 |
Why?
| Testosterone | 2 | 2019 | 373 | 0.040 |
Why?
| Collagen Type I | 1 | 2021 | 117 | 0.040 |
Why?
| Torque | 1 | 2001 | 84 | 0.040 |
Why?
| Electrodes | 1 | 2001 | 103 | 0.040 |
Why?
| Aged | 5 | 2011 | 21953 | 0.040 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 52 | 0.040 |
Why?
| Detergents | 1 | 2000 | 45 | 0.040 |
Why?
| Chromatography, Gel | 1 | 2000 | 127 | 0.040 |
Why?
| Cytotoxicity, Immunologic | 1 | 2020 | 218 | 0.040 |
Why?
| Serine | 1 | 2021 | 135 | 0.040 |
Why?
| L-Lactate Dehydrogenase | 1 | 2000 | 116 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 323 | 0.040 |
Why?
| Solubility | 1 | 2000 | 229 | 0.040 |
Why?
| Tumor Burden | 1 | 2020 | 283 | 0.040 |
Why?
| Cell Membrane | 2 | 2000 | 720 | 0.040 |
Why?
| Glycogen | 1 | 1999 | 55 | 0.040 |
Why?
| Mice, SCID | 1 | 2000 | 350 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 421 | 0.040 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2000 | 185 | 0.040 |
Why?
| Eating | 1 | 2021 | 368 | 0.040 |
Why?
| Isometric Contraction | 1 | 2001 | 187 | 0.040 |
Why?
| Swine | 2 | 2013 | 742 | 0.040 |
Why?
| Rats, Sprague-Dawley | 1 | 2024 | 2239 | 0.040 |
Why?
| Glucose Transporter Type 4 | 1 | 2018 | 39 | 0.040 |
Why?
| Glucagon | 1 | 1999 | 105 | 0.040 |
Why?
| Osmolar Concentration | 1 | 1999 | 164 | 0.040 |
Why?
| Pilot Projects | 1 | 2023 | 1563 | 0.040 |
Why?
| Disease Models, Animal | 3 | 2015 | 3937 | 0.040 |
Why?
| Muscle Proteins | 1 | 2000 | 221 | 0.040 |
Why?
| Postprandial Period | 1 | 1999 | 103 | 0.040 |
Why?
| Perception | 1 | 2001 | 338 | 0.040 |
Why?
| Research Design | 1 | 2024 | 1036 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2020 | 385 | 0.040 |
Why?
| Dendritic Cells | 1 | 2020 | 479 | 0.030 |
Why?
| Immunity, Innate | 1 | 2023 | 802 | 0.030 |
Why?
| Random Allocation | 1 | 2018 | 343 | 0.030 |
Why?
| Carbon Dioxide | 1 | 1999 | 260 | 0.030 |
Why?
| Cell Proliferation | 2 | 2015 | 2344 | 0.030 |
Why?
| Cell Line, Tumor | 2 | 2015 | 3184 | 0.030 |
Why?
| Nutritional Status | 1 | 1999 | 325 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2017 | 101 | 0.030 |
Why?
| Carrier Proteins | 1 | 2000 | 732 | 0.030 |
Why?
| Deuterium | 1 | 2015 | 86 | 0.030 |
Why?
| Waist Circumference | 1 | 2015 | 138 | 0.030 |
Why?
| Prospective Studies | 2 | 2018 | 7036 | 0.030 |
Why?
| Androgens | 1 | 2016 | 173 | 0.030 |
Why?
| HeLa Cells | 1 | 2017 | 603 | 0.030 |
Why?
| Lymphocyte Activation | 3 | 1994 | 1098 | 0.030 |
Why?
| Double-Blind Method | 1 | 2019 | 1848 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2020 | 846 | 0.030 |
Why?
| Epitopes | 1 | 1997 | 466 | 0.030 |
Why?
| Protein Subunits | 1 | 2015 | 230 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 265 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 39 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 80 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 56 | 0.030 |
Why?
| Animal Feed | 1 | 2014 | 50 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2020 | 1181 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1105 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 480 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1997 | 375 | 0.030 |
Why?
| Memory | 1 | 2015 | 232 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 1994 | 402 | 0.030 |
Why?
| Risk Factors | 3 | 2012 | 9704 | 0.030 |
Why?
| Infant, Newborn | 1 | 2024 | 5687 | 0.030 |
Why?
| Acyl Coenzyme A | 1 | 2013 | 30 | 0.030 |
Why?
| Macrophage Activation | 1 | 2014 | 187 | 0.030 |
Why?
| Prevalence | 1 | 2019 | 2547 | 0.030 |
Why?
| Amyloid beta-Peptides | 1 | 2015 | 211 | 0.030 |
Why?
| Heart Function Tests | 1 | 2013 | 59 | 0.030 |
Why?
| Gonanes | 1 | 2012 | 27 | 0.030 |
Why?
| Cardiolipins | 1 | 2013 | 83 | 0.020 |
Why?
| Anaerobic Threshold | 2 | 2004 | 27 | 0.020 |
Why?
| Models, Theoretical | 1 | 2015 | 542 | 0.020 |
Why?
| Fetus | 1 | 2016 | 760 | 0.020 |
Why?
| Antigen-Presenting Cells | 1 | 1992 | 150 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 1994 | 930 | 0.020 |
Why?
| Cerebral Cortex | 1 | 2015 | 423 | 0.020 |
Why?
| Behavior, Animal | 1 | 2015 | 484 | 0.020 |
Why?
| Models, Statistical | 1 | 2015 | 621 | 0.020 |
Why?
| Abdominal Fat | 1 | 2012 | 40 | 0.020 |
Why?
| Molecular Weight | 1 | 2012 | 331 | 0.020 |
Why?
| Learning | 1 | 2015 | 396 | 0.020 |
Why?
| Cognition Disorders | 1 | 2015 | 497 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 302 | 0.020 |
Why?
| Tomography, X-Ray Computed | 2 | 2010 | 2523 | 0.020 |
Why?
| Hippocampus | 1 | 2015 | 801 | 0.020 |
Why?
| Receptors, Progesterone | 1 | 2012 | 341 | 0.020 |
Why?
| Genotype | 1 | 2015 | 1828 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2011 | 203 | 0.020 |
Why?
| Abdomen | 1 | 2010 | 116 | 0.020 |
Why?
| Child, Preschool | 1 | 2024 | 10384 | 0.020 |
Why?
| Sex Distribution | 1 | 2010 | 358 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2018 | 4892 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 511 | 0.020 |
Why?
| Mice, Knockout | 1 | 2015 | 2755 | 0.020 |
Why?
| Spleen | 1 | 2010 | 507 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2010 | 374 | 0.020 |
Why?
| Leydig Cells | 1 | 1988 | 13 | 0.020 |
Why?
| Environmental Monitoring | 1 | 2010 | 322 | 0.020 |
Why?
| Gonadotropins, Pituitary | 1 | 1988 | 22 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2435 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 357 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2018 | 3376 | 0.020 |
Why?
| B-Lymphocytes | 1 | 1992 | 817 | 0.020 |
Why?
| Macrophages | 1 | 2014 | 1460 | 0.020 |
Why?
| Patient Selection | 1 | 2010 | 663 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 1983 | 0.020 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 413 | 0.020 |
Why?
| Amino Acid Sequence | 2 | 2000 | 2040 | 0.020 |
Why?
| Molecular Sequence Data | 2 | 2000 | 2819 | 0.010 |
Why?
| Age Factors | 1 | 2012 | 3103 | 0.010 |
Why?
| Femoral Vein | 1 | 2004 | 32 | 0.010 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2004 | 126 | 0.010 |
Why?
| Hormones | 1 | 2004 | 140 | 0.010 |
Why?
| Alanine | 1 | 2004 | 141 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2654 | 0.010 |
Why?
| Femoral Artery | 1 | 2004 | 170 | 0.010 |
Why?
| Blood Pressure | 1 | 2009 | 1728 | 0.010 |
Why?
| Glycolysis | 1 | 2004 | 293 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 2010 | 999 | 0.010 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2000 | 20 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2012 | 2132 | 0.010 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 73 | 0.010 |
Why?
| Glucose-6-Phosphatase | 1 | 1999 | 31 | 0.010 |
Why?
| Isoenzymes | 1 | 2000 | 304 | 0.010 |
Why?
| Mice, Obese | 1 | 1999 | 57 | 0.010 |
Why?
| Myosin Heavy Chains | 1 | 2000 | 173 | 0.010 |
Why?
| Fishes | 1 | 1999 | 93 | 0.010 |
Why?
| Open Reading Frames | 1 | 1999 | 116 | 0.010 |
Why?
| Conserved Sequence | 1 | 1999 | 227 | 0.010 |
Why?
| Sequence Alignment | 1 | 1999 | 329 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 367 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 1999 | 338 | 0.010 |
Why?
| Cloning, Molecular | 1 | 1999 | 522 | 0.010 |
Why?
| Dogs | 1 | 1999 | 366 | 0.010 |
Why?
| Exons | 1 | 1999 | 338 | 0.010 |
Why?
| Alternative Splicing | 1 | 1999 | 217 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1999 | 1228 | 0.010 |
Why?
| Base Sequence | 1 | 1999 | 2135 | 0.010 |
Why?
| Models, Molecular | 1 | 1999 | 1480 | 0.010 |
Why?
| Genetic Variation | 1 | 1999 | 933 | 0.010 |
Why?
| Trinitrobenzenes | 1 | 1992 | 14 | 0.010 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.010 |
Why?
| Hybrid Cells | 1 | 1992 | 50 | 0.010 |
Why?
| Haptens | 1 | 1992 | 22 | 0.010 |
Why?
| Ovalbumin | 1 | 1992 | 177 | 0.010 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 126 | 0.010 |
Why?
| Interleukin-2 | 1 | 1992 | 434 | 0.010 |
Why?
| Mice, Mutant Strains | 1 | 1989 | 292 | 0.000 |
Why?
| Islets of Langerhans Transplantation | 1 | 1989 | 60 | 0.000 |
Why?
| Pituitary Gland | 1 | 1989 | 148 | 0.000 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|